Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Starbreeze AB | 34,529 | net | 17 Nov 2023 | tx 2+34,529 |
| Oncopeptides AB | 19,951 | net | 17 Mar 2026 | tx 2+19,951 |
| Cherry AB | 15,170 | net | 30 Jun 2017 | tx 2+15,170 |
| Orexo AB | 11,241 | net | 23 May 2025 | tx 4+11,241 |
| BONESUPPORT HOLDING AB | 3,312 | net | 12 May 2026 | tx 5+3,312 |
| 4C Group AB | 850 | net | 24 May 2022 | tx 1+850 |
| Serneke Group AB | 500 | net | 28 Nov 2016 | tx 2+500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | PURCHASE | BONESUPPORT HOLDING AB | 534 | 234.52 SEK | |
| 17 Mar 2026 | PURCHASE | Oncopeptides AB | 14,631 | 1.63 SEK | |
| 15 Sept 2025 | PURCHASE | Oncopeptides AB | 5,320 | 3.20 SEK | |
| 28 May 2025 | PURCHASE | BONESUPPORT HOLDING AB | 443 | 254.40 SEK | |
| 23 May 2025 | PURCHASE | Orexo AB | 3,314 | 15.38 SEK | |
| 12 Jul 2024 | PURCHASE | BONESUPPORT HOLDING AB | 369 | 272.84 SEK | |
| 07 Jun 2024 | PURCHASE | Orexo AB | 2,332 | 21.28 SEK | |
| 29 Nov 2023 | PURCHASE | BONESUPPORT HOLDING AB | 571 | 174.98 SEK | |
| 17 Nov 2023 | PURCHASE | Starbreeze AB | 26,199 | 0.46 SEK | first after silence |
| 17 Nov 2023 | PURCHASE | Orexo AB | 2,920 | 15.39 SEK | |
| 20 Jun 2023 | GRANT_AWARD | Starbreeze AB | 8,330 | 0.75 SEK | |
| 14 Jul 2022 | PURCHASE | Orexo AB | 2,675 | 22.47 SEK | |
| 03 Jun 2022 | PURCHASE | BONESUPPORT HOLDING AB | 1,395 | 61.57 SEK | |
| 24 May 2022 | PURCHASE | 4C Group AB | 850 | 35.00 SEK | first after silence |
| 30 Jun 2017 | PURCHASE | Cherry AB | 15,000 | 19.68 SEK | |
| 16 Jun 2017 | PURCHASE | Cherry AB | 170 | 295.00 SEK | |
| 28 Nov 2016 | PURCHASE | Serneke Group AB | 250 | 104.50 SEK | |
| 24 Nov 2016 | PURCHASE | Serneke Group AB | 250 | 110.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 17 Nov 2023.